Patients with nasopharyngeal cancer are often vaccinated with drugs that activate their immune system against the tumor. It was feared that a vaccination against Covid-19 could reduce the success of the treatment or cause side effects.
According to studies by the Universities of Bonn and the People's Republic of China now give the all-clear in this regard. According to the study, the cancer drugs worked better after vaccination with the Chinese vaccine SINOVAC than in unvaccinated patients.
The results published in the "Annals of Oncology" states that the drugs are available for use.
No comments:
Post a Comment